4-ipomeanol has been researched along with Glioma in 1 studies
*Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, DY; Jang, SJ; Kang, JH; Kim, SE; Kim, SJ; Lee, BC; Lee, TS; Moon, BS | 1 |
1 other study(ies) available for 4-ipomeanol and Glioma
| Article | Year |
|---|---|
Synthesis and evaluation of a 18F-labeled 4-ipomeanol as an imaging agent for CYP4B1 gene prodrug activation therapy.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Drug Stability; Fluorine Radioisotopes; Glioma; Humans; Isotope Labeling; Prodrugs; Radiopharmaceuticals; Rats; Rats, Inbred F344; Terpenes; Transfection; Tumor Cells, Cultured | 2013 |